---
trial_id: 864
discovery_date: 2022-06-09 18:59:43.960254
date: 2022-06-09 18:59:43.960254
title: "A Phase I&#x2F;Ib, Open-label, Multi-center, Study of KAZ954 as a Single Agent and in Combination With Spartalizumab, NZV930 and NIR178 in Patients With Advanced Solid Tumors"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04237649'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
